v3.26.3
Unaudited Interim Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Consolidated Statements of Comprehensive Income Loss [Abstract]    
Revenue $ 6,208 $ 2,265
Cost of Revenue 2,645 1,452
Gross profit 3,563 813
Research and development expenses 479 384
Selling and marketing expenses 2,134 539
General and administrative expenses 1,653 1,499
Operating Loss 703 1,609
Finance Expenses 109 65
Finance Income 80 38
Net Loss for the period (732) (1,636)
Amounts that shall not be subsequently reclassified to profit and loss:    
Loss from remeasurement of defined benefit plans
Total comprehensive loss for the period $ (732) $ (1,636)
Basic loss per share (in Dollars per share) $ (0.1103) $ (0.2736)
Weighted average of the number of ordinary shares used to calculate basic loss per share (in Shares) 6,634,400 5,980,013
Diluted loss per share (in Dollars per share) $ (0.1103) $ (0.2736)
Weighted average of the number of ordinary shares used to calculate diluted loss per share (in Shares) 6,634,400 5,980,013